PubRank

Manuela Ferracin

Author PubWeight™ 212.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006 40.09
2 MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005 27.56
3 A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005 26.02
4 miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005 21.51
5 MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004 14.59
6 An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 2004 13.66
7 A microRNA signature of hypoxia. Mol Cell Biol 2006 7.24
8 Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007 5.40
9 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007 5.40
10 Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007 4.35
11 MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008 4.33
12 Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005 3.35
13 CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res 2013 2.57
14 mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007 2.40
15 Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 2010 2.30
16 MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009 2.16
17 Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 2010 2.05
18 MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007 2.00
19 MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009 1.97
20 MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 2009 1.84
21 Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009 1.70
22 Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 2008 1.68
23 Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 2010 1.53
24 Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010 1.52
25 Regulation of microRNA expression: the hypoxic component. Cell Cycle 2007 1.49
26 Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 2007 1.37
27 miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol 2012 1.34
28 Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 2012 1.23
29 Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. Int J Oncol 2009 1.11
30 miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 2013 1.10
31 Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci U S A 2011 1.08
32 MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol 2011 1.06
33 MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic Biol Med 2008 0.99
34 Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. Mol Med 2013 0.95
35 Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res 2013 0.92
36 A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines. Oncotarget 2013 0.89
37 miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Front Genet 2013 0.89
38 Tumor suppressor functions of ARLTS1 in lung cancers. Cancer Res 2007 0.87
39 STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica 2013 0.86
40 Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. Mol Cancer 2013 0.86
41 Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment. Leuk Res 2010 0.85
42 Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis. Stem Cells 2015 0.84
43 First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 2013 0.83
44 Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. Oncotarget 2014 0.80
45 Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4. BMC Res Notes 2010 0.79
46 An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. Thromb Haemost 2014 0.78
47 Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes. J Cell Physiol 2015 0.77
48 OncomiR detection in circulating body fluids: a PDMS microdevice perspective. Lab Chip 2014 0.75